Viberzi denied as non-formulary by Cigna?

Cigna's specific coverage criteria for viberzi are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna May Deny Viberzi as Non-Formulary

A non-formulary denial means Viberzi (eluxadoline) is not included on Cigna's current drug formulary for your specific plan, or it is placed on a tier that your benefit level does not cover without special approval. Formularies change annually and vary by employer plan, so a drug excluded under one plan year may be covered under another — or may be accessible through an exceptions process.

## Why This Denial Is Appealable

Cigna's plans typically include a formulary exception process that allows coverage of a non-formulary drug when a covered alternative is clinically inappropriate for a specific patient. If you have tried formulary alternatives for IBS-D and they were ineffective or caused adverse effects, or if your prescriber can document a clinical reason you cannot use the formulary alternatives, a formulary exception appeal is a well-established pathway.

## Your Federal Appeal Rights

Under ACA §2719, you have the right to an internal appeal of a non-formulary denial, followed by independent external review if the internal appeal is denied. Under ERISA §503, self-funded plans must provide full-and-fair review procedures. The external-review request window is generally approximately four months from denial. Expedited review is available in urgent clinical situations.

## The Appeal Process

1. Identify formulary alternatives. Request from Cigna the list of covered formulary drugs for IBS-D at your benefit tier. These are what the plan considers therapeutically comparable. 2. Formulary exception request (concurrent with or before appeal). Your prescriber submits a formulary exception request explaining why each listed formulary alternative is clinically inappropriate, contraindicated, or was previously tried and failed. 3. Formal internal appeal. If the exception is denied, file a written internal appeal with the full documentation package. 4. External review. Escalate to independent external review if the internal appeal is denied.

## Documentation to Gather

• Diagnosis confirmation: Chart notes confirming IBS-D diagnosis.
• Formulary alternative trial history: For each covered formulary IBS-D drug, documented dates of use, outcomes, and specific reasons for failure or intolerance.
• Prescriber exception letter: Detailed explanation of why Viberzi is medically necessary and each formulary alternative is inadequate for this patient.
• Clinical severity documentation: Chart entries showing ongoing symptom burden despite any formulary drugs tried.

## Criteria-Mapping Structure

Obtain Cigna's formulary exception criteria from the plan documents or Member Services. List each criterion required for a formulary exception, then document the specific chart fact addressing each one. Your prescriber's letter should mirror this structure — criterion by criterion — so the reviewer can match each claim to an evidence source. Verify exact eligibility requirements against the FDA-approved prescribing label and Cigna's current published coverage policy, not third-party summaries.